Anlon Healthcare Approves Sub-division of Equity Shares, Increase in Authorized Share Capital, and Alteration to the Capital Clause

Anlon Healthcare Limited has informed the Exchange that the Board of Directors at its meeting held on March 06, 2026, has considered and approved several significant changes. The changes include the sub-division of equity shares from a face value of Rs.10/- each to a face value of Rs.02/- each, alteration of the capital clause of the Memorandum of Association of the Company, increase in authorized share capital, and issue of bonus shares in the ratio of 1:1. These changes aim to enhance liquidity and enable higher participation from public shareholders.